Dataset Information


L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.

ABSTRACT: Cervical cancer is associated with infection by certain subtypes of human papillomavirus (HPV). The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing antibodies and confers protection against specific HPV subtypes. HPV L2 protein is an attractive candidate for cross-protective vaccines. HPV-33 and HPV-58 are very prevalent among Chinese women.To study the gene intratypic variations and polymorphisms of HPV-33 and HPV-58?L1/L2 in Sichuan China, HPV-33 and HPV-58?L1 and L2 genes were sequenced and compared with other genes submitted to GenBank. Phylogenetic trees were constructed by maximum-likelihood and the Kimura 2-parameters methods (MEGA 6). The secondary structure was analyzed by PSIPred software, and HPV-33 and HPV-58 L1 homology models were created by SWISS-MODEL software. The selection pressures acting on the L1/L2 genes were estimated by PAML 4.8.Among 124 HPV-33?L1 sequences 20 single nucleotide mutations were observed included 8/20 non-synonymous and 12/20 synonymous mutations. The 101 HPV-33?L2 sequences included 12 single nucleotide mutations comprising 7/12 non-synonymous and 5/12 synonymous mutations. The 223 HPV-58?L1 sequences included 32 single nucleotide mutations comprising 9/32 non-synonymous and 23/32 synonymous mutations. The 201 HPV-58?L2 sequences comprised 26 single nucleotide mutations including 9/26 non-synonymous and 17/26 synonymous mutations. Selective pressure analysis showed that most of the common non-synonymous mutations showed a positive selection. HPV-33 and HPV-58?L2 were more stable than HPV-33 and HPV-58?L1.HPV-33 and HPV-58?L2 were better candidates as clinical diagnostic targets compared with HPV-33 and HPV-58?L1. Clinical diagnostic probes and second-generation polyvalent vaccines should be designed on the basis of the unique sequence of HPV-33 and 58?L1/L2 variations in Sichuan, to improve the accuracy of clinical detection and the protective efficiency of vaccines.


PROVIDER: S-EPMC5055703 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3555822 | BioStudies
2017-01-01 | S-EPMC5283733 | BioStudies
2019-01-01 | S-EPMC7019592 | BioStudies
2019-01-01 | S-EPMC6597877 | BioStudies
2013-01-01 | S-EPMC3826974 | BioStudies
2018-01-01 | S-EPMC5928666 | BioStudies
2015-01-01 | S-EPMC4408011 | BioStudies
2013-01-01 | S-EPMC3581518 | BioStudies
2017-01-01 | S-EPMC5609925 | BioStudies
2019-01-01 | S-EPMC6811573 | BioStudies